Adar -associated Aicardi Goutières syndrome in a child with bilateral striatal necrosis and recurrent episodes of transaminitis.
Ronald van ToornMagriet van NiekerkShahida MoosaSavvas AndronikouRegan S SolomonsPublished in: BMJ case reports (2023)
Aicardi-Goutières syndrome (AGS) refers to a group of genetic diseases characterised by severe inflammatory encephalopathy that usually present within the first year of life, resulting in progressive loss of cognition, spasticity, dystonia and motor disability. Pathogenic variants in the adenosine deaminase acting on RNA ( Adar ) enzyme have been linked to AGS type 6 (AGS6, Online Mendelian Inheritance in Man (OMIM) 615010). In knockout mouse models, loss of Adar activates the interferon (IFN) pathway and causes autoimmune pathogenesis in the brain or liver. Bilateral striatal necrosis (BSN) has previously been reported in case series of children with biallelic pathogenic variants in Adar We describe a unique, previously unreported case of a child with AGS6, with clinical manifestations of BSN and recurrent transient episodes of transaminitis. The case highlights the importance of Adar in protecting the brain and liver from IFN-induced inflammation. Adar -related disease should therefore be considered in the differential diagnosis of BSN accompanied by recurrent episodes of transaminitis.
Keyphrases
- multiple sclerosis
- early onset
- copy number
- white matter
- case report
- resting state
- functional connectivity
- dendritic cells
- oxidative stress
- mental health
- cerebral ischemia
- parkinson disease
- drug induced
- immune response
- mitochondrial dna
- young adults
- spinal cord injury
- healthcare
- deep brain stimulation
- high glucose
- genome wide
- intellectual disability
- endothelial cells
- blood brain barrier
- upper limb